Senate health committee chair Bernie Sanders has called a vote to subpoena the chief of Novo Nordisk’s U.S. division over the company’s pricing of Ozempic and Wegovy.
I don’t believe it’s actually $90 anywhere, that must be because of some sort of subsidy.
In Denmark where Novo resides, the price is $200+ for the lowest dose. And Denmark allows parallel import if it can be bought cheaper elsewhere.
USA has a very different market, with extreme penalties in case something goes wrong, that mandates higher self insurance, and sales channels that are almost built for abuse by almost everybody. I seriously doubt Novo makes 6 times more on Wegovy than they do elsewhere. The problem is in the American system.
That said, I agree with Bernie Sanders that there’s a problem that needs to be fixed.
If the prices are as legitimate as you suggest then surely that will be easily revealed by the subpoena’d accounting books and Novo Nordisk will be cleared of suspicion. Wouldn’t that be the system working as intended?
I don’t believe it’s actually $90 anywhere, that must be because of some sort of subsidy.
In Denmark where Novo resides, the price is $200+ for the lowest dose. And Denmark allows parallel import if it can be bought cheaper elsewhere.
USA has a very different market, with extreme penalties in case something goes wrong, that mandates higher self insurance, and sales channels that are almost built for abuse by almost everybody. I seriously doubt Novo makes 6 times more on Wegovy than they do elsewhere. The problem is in the American system.
That said, I agree with Bernie Sanders that there’s a problem that needs to be fixed.
If the prices are as legitimate as you suggest then surely that will be easily revealed by the subpoena’d accounting books and Novo Nordisk will be cleared of suspicion. Wouldn’t that be the system working as intended?